Fundraising FoxPotenza Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into Potenza Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
189 people can intro you to Reid
Ask Elizabeth Stoner to introduce you to Reid Leonard
You →Elizabeth · together at Potenza Therapeutics →Reid
68 people can intro you to Dan
Ask Jamie Chen to introduce you to Dan Hicklin
You →Jamie · together at Werewolf Therapeutics →Dan
Sign up to find every way you can get introduced to Potenza Therapeutics
- Your email: who you already know at Potenza Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Potenza Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
CS
Cynthia Seidel-DuganExecutive
DC
David CordoExecutive
DH
RL
Reid LeonardChief Operating Officer2018–2018Dr. Reid Leonard is Chief Operating Officer of Potenza Therapeutics, an immune-oncology company that he co-founded in 2014 and led through business development and corporate strategy roles before its acquisition by Astellas Pharma. Previously, he spent 25 years at Merck & Co. in drug discovery and business development focused on ion channels and GPCR signaling, and holds a Ph.D. in neuroscience from Purdue University and a B.A. from Brandeis University.
Board
AO
Arnold OronskyBoard director
LE
SA
Sakae AsanumaBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$35M disclosed across 2 rounds · 2014–2017
▶$5MraisedDec 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$5MraisedDec 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shunichiro MatsumotoDirector
- Luke EvninDirector
- Cynthia Seidel-DuganExecutive Officer
- Reid LeonardExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Arnold OronskyDirector
- David CordoExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$30MraisedMar 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$30MraisedMar 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia Seidel-DuganExecutive Officer
- David CordoExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Arnold OronskyDirector
- Reid LeonardExecutive Officer
- Luke EvninDirector
- Sakae AsanumaDirector
- Offering amount
- $38M
- Amount sold
- $30M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Potenza Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Potenza Therapeutics's investors?
- Potenza Therapeutics's investors include MPM BioImpact.
- How much funding has Potenza Therapeutics raised?
- Potenza Therapeutics has disclosed $35M raised across 2 rounds.
- Where is Potenza Therapeutics headquartered?
- Potenza Therapeutics is headquartered in Cambridge, US.